VITROS Immunodiagnostic Products CA 19-9TM Reagent Pack

FDA 510(k) K231525 · Ortho Clinical Diagnostics

Substantially Equivalent

510(k) numberK231525

Submission

Device name
VITROS Immunodiagnostic Products CA 19-9TM Reagent Pack
Applicant
Ortho Clinical Diagnostics
Bridgend, GB
Received
May 26, 2023
Decision date
August 9, 2023
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
NIG – System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer
Device class
Class II (moderate risk)
Regulation
21 CFR 866.6010
Specialty
Immunology

An in vitro diagnostic test for the quantitative measurement of the CA 19-9 tumor associated antigen in human serum or plasma. The test is intended as an aid in the management of patients with confirmed pancreatic cancer and serial monitoring of their response to therapy and disease progression. The test should only be used in patients with serum and plasma CA 19-9 values above the cut-off at…

Other 510(k)s with product code NIG

510(k)DeviceApplicantDecision
K253528Atellica IM CA 19-9 IINIG · Traditional Siemens Healthcare Diagnostics, Inc.08/10/2026SE
K200997Lumipulse G CA19-9-NNIG · Special Fujirebio Diagnostics,Inc.05/14/2020SE
K191973Lumpipulse G CA19-9-NNIG · Traditional Fujirebio Dianostics, Inc.10/22/2019SE
K100375Dimension Vista Loci Ca 19-9 Flex Reagent Cartridge, and Dimension LOCI7 Calibrator with…NIG · Traditional Siemens Healthcare Diagnostics, Inc.04/06/2011SE
K052889Vitros Ca 19-9NIG · Traditional Fujirebio Diagnostics,Inc.12/20/2005SE
K052000Architect Ca 19-9XR AssayNIG · Traditional Fujirebio Diagnostics,Inc.10/25/2005SE
K033038Gi Monitor and Gi Monitor Calibrators on the Access Immunoassay Systems, Model 387687…NIG · Traditional Beckman Coulter, Inc.12/29/2003SE
K031393Bayer Advia Centaur Ca 19-9 AssayNIG · Traditional Bayer Healthcare, LLC06/24/2003SE
K023240ST Aia-Pack Ca 19-9NIG · Traditional Tosoh Corp.12/23/2002SE
K023239Aia-Pack Ca 19-9NIG · Traditional Tosoh Corp.12/23/2002SE

More from Tosoh Corp.

510(k)DeviceDecision
K252393VITROS Immunodiagnostic Products hs Troponin I Reagent PackMMI · Traditional 10/29/2025SE
K241534VITROS Immunodiagnostic Products Syphilis Reagent PackLIP · Traditional 08/28/2024SE
K233581VITROS Immunodiagnostic Products Total ß-hCG II Reagent PackDHA · Traditional 05/08/2024SE
K221197VITROS Immunodiagnostic Products Intact PTH II Reagent PackCEW · Traditional 09/05/2023SE
K231517VITROS Immunodiagnostic Products CEA Reagent PackDHX · Traditional 08/23/2023SE
K221355VITROS Immuodiagnostic Products CA 125 II Reagent PackLTK · Traditional 12/12/2022SE
K213626Vitros AfpLOJ · Traditional 06/15/2022SE
K212648VITROS Immunodiagnostic Products CK-MB Reagent PackJHX · Traditional 01/28/2022SE
K201312VITROS Immunodiagnostic Products NT-proBNP II Reagent PackNBC · Traditional 10/04/2021SE
K210858VITROS Chemistry Products PHBR SlidesDLZ · Traditional 08/13/2021SE

Questions and answers

When was VITROS Immunodiagnostic Products CA 19-9TM Reagent Pack cleared by the FDA?

VITROS Immunodiagnostic Products CA 19-9TM Reagent Pack (K231525) received a 510(k) decision of Substantially Equivalent on August 9, 2023, 75 days after the submission was received.

What is the product code of K231525?

The FDA product code is NIG – System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer, a Class II (moderate risk) device regulated under 21 CFR 866.6010.